ImetelChat

After watching not only the patient testimonials but I think just as importantly the docs who have used it - I said no way this doesn’t pass - surprised 2 people still voted no

I think we will be approved before June 16

Someone asked about the 4 years of TI and I was unable to respond - I believe Dr Faye Feller said they just dosed a patient for their 4th year of TI and also Dr Valeria Santini said she had a patient approaching 4 years of TI

Believe it was the guy from university if Virginia

1 FDA approval 2 I expect an announcement on a European partnership to be announced soon after FDA approval 3 European approval The name and details of the European partner have the potential to move the price significantly - I think the FDA and European approvals are expected but the partnership ha...

I think the after hours volume is more impressive than the price - tomorrow will be interesting

why do I feel like there was a lot of manipulation today that benefited certain people

Thanks - you all have made me feel better

https://x.com/adamfeuerstein/status/176 ... CXgoldHN1Q

Not a fan of his

I have not chatted a chance to read through all of the documents, but supposedly the FDA said there are two cases of hy’s law in imetelstat arm - this according to Fauerstein - supposedly Garon submitted documents from a liver panel of experts that disagreed with this

this is excellent - was posted yesterday by Biopearl

I don’t see anything - probably trying to keep the price down

I know the push for the Luspatercept is largely based on convenience of not needing an infusion - we know the results are not comparable in terms of HgB increase - and the most important thing is QOL - I think this might end up being a much bigger factor then we have been thinking - Most people woul...

I think the FDA will want to look at all available data regarding imetelstat - even tho the review is for MDS it would be negligent not to look at the other studies that are ongoing

i missed it also

over 55 million shares or 9.99 percent - going to 10 percent becomes ornerus from a SEC reporting perspective so basically they are maxed out

I was thinking the same - they were told there was a promising drug for heme malignancies named imetelstat and they assumed for MM - now the Geron job posting for sales reps says for heme malignancies and not just MDS and MF - i think we can expect imetelstat will be used for PV ET MDS and a good ch...

i am replying to my own post if this is allowed - where did the multiple myeloma come from? is this from Dr Lane (article from australia) - is it easier to try things there vs US or Europe? I think a lot of things are going on that we do not know about

https://x.com/Dr_AmerZeidan/status/1755 ... 80056?s=20

I would expect him to be part of the ADCOM - he was disappointed imetelstat was not approved in 2023